Clinical Trial Update: Docetaxel Based Anthracycline Free Adjuvant Treatment Evaluation, as Well as Life Style Intervention [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating a docetaxel-based, anthracycline-free adjuvant regimen for breast cancer, with a lifestyle intervention component.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Philip Hepp | Conditions: Breast Cancer | Phase 3 | Status: UNKNOWN